Concepedia

Kai Chio Chan

KC

Statistics

Publications

11

Citations

726

H-Index

11

Active since

2001

Affiliations

University of Manchester(Current)

Henry Royce Institute

Johnson & Johnson (United Kingdom)

University of California, Los Angeles

Johnson & Johnson (United States)

Kai Chio Chan is an author at University of Manchester specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2001–2024

11

Publications

11

ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression

Neil G. Anderson, Tawhid Ahmad, Kai Chio Chan et al. · International Journal of Cancer · 2001 · 195 citations

, , +14

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma <i>in situ</i> after breast-conserving surgery

G.P. Boland, Kai Chio Chan, W.F. Knox et al. · British journal of surgery · 2003 · 94 citations · Full text

Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.

Kai Chio Chan, W.F. Knox, Julia M.W. Gee et al. · PubMed · 2002 · 94 citations

, , +12

Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ

Kai Chio Chan, W.F. Knox, Guria Sinha et al. · Cancer · 2001 · 74 citations

Blockade of growth factor receptors in ductal carcinoma <i>in situ</i> inhibits epithelial proliferation

Kai Chio Chan, W.F. Knox, Ashu Gandhi et al. · British journal of surgery · 2001 · 68 citations · Full text

1–5 of 11